243 related articles for article (PubMed ID: 29409796)
1. The anti-diabetic drug dapagliflozin induces vasodilation via activation of PKG and Kv channels.
Li H; Shin SE; Seo MS; An JR; Choi IW; Jung WK; Firth AL; Lee DS; Yim MJ; Choi G; Lee JM; Na SH; Park WS
Life Sci; 2018 Mar; 197():46-55. PubMed ID: 29409796
[TBL] [Abstract][Full Text] [Related]
2. The anti-diabetic drug repaglinide induces vasorelaxation via activation of PKA and PKG in aortic smooth muscle.
Kim HW; Li H; Kim HS; Shin SE; Jung WK; Ha KS; Han ET; Hong SH; Choi IW; Firth AL; Bang H; Park WS
Vascul Pharmacol; 2016 Sep; 84():38-46. PubMed ID: 27435474
[TBL] [Abstract][Full Text] [Related]
3. Empagliflozin dilates the rabbit aorta by activating PKG and voltage-dependent K
Seo MS; Jung HS; An JR; Kang M; Heo R; Li H; Han ET; Yang SR; Cho EH; Bae YM; Park WS
Toxicol Appl Pharmacol; 2020 Sep; 403():115153. PubMed ID: 32717242
[TBL] [Abstract][Full Text] [Related]
4. The antidiabetic drug teneligliptin induces vasodilation via activation of PKG, Kv channels, and SERCA pumps in aortic smooth muscle.
Li H; An JR; Park M; Choi J; Heo R; Kang M; Mun SY; Zhuang W; Seo MS; Han ET; Han JH; Chun W; Park WS
Eur J Pharmacol; 2022 Nov; 935():175305. PubMed ID: 36183856
[TBL] [Abstract][Full Text] [Related]
5. The anti-diabetic drug alogliptin induces vasorelaxation via activation of Kv channels and SERCA pumps.
Jung HS; Seo MS; An JR; Heo R; Kang M; Han ET; Park H; Song G; Son YK; Jung WK; Choi IW; Na SH; Park WS
Eur J Pharmacol; 2021 May; 898():173991. PubMed ID: 33684451
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase-4 inhibitor sitagliptin induces vasorelaxation via the activation of Kv channels and PKA.
Li H; Seo MS; An JR; Jung HS; Ha KS; Han ET; Hong SH; Bae YM; Na SH; Park WS
Toxicol Appl Pharmacol; 2019 Dec; 384():114799. PubMed ID: 31678606
[TBL] [Abstract][Full Text] [Related]
7. The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage-dependent K
Li H; Kim HW; Shin SE; Seo MS; An JR; Jung WK; Ha KS; Han ET; Hong SH; Bang H; Choi IW; Na SH; Park WS
Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 28834298
[TBL] [Abstract][Full Text] [Related]
8. The vasodilatory effect of the antidiabetic drug linagliptin via inhibition of Rho-associated protein kinase in aortic smooth muscle.
Seo MS; Li H; An JR; Jang JH; Jung HS; Kim T; Kook S; Jung WK; Choi IW; Na SH; Park WS
Life Sci; 2019 Feb; 219():1-10. PubMed ID: 30620894
[TBL] [Abstract][Full Text] [Related]
9. The anti-diabetic drug trelagliptin induces vasodilation via activation of Kv channels and SERCA pumps.
Heo R; Seo MS; An JR; Kang M; Park H; Han ET; Han JH; Chun W; Park WS
Life Sci; 2021 Oct; 283():119868. PubMed ID: 34358551
[TBL] [Abstract][Full Text] [Related]
10. The vasodilatory effect of gemigliptin via activation of voltage-dependent K
Jung HS; Seo MS; An JR; Kang M; Heo R; Li H; Jung WK; Choi IW; Cho EH; Park H; Bae YM; Park WS
Eur J Pharmacol; 2020 Sep; 882():173243. PubMed ID: 32535099
[TBL] [Abstract][Full Text] [Related]
11. Vildagliptin, an Anti-diabetic Drug of the DPP-4 Inhibitor, Induces Vasodilation via Kv Channel and SERCA Pump Activation in Aortic Smooth Muscle.
Seo MS; Li H; An JR; Jung ID; Jung WK; Ha KS; Han ET; Hong SH; Choi IW; Park WS
Cardiovasc Toxicol; 2019 Jun; 19(3):244-254. PubMed ID: 30519910
[TBL] [Abstract][Full Text] [Related]
12. The vasorelaxant effect of mitiglinide via activation of voltage-dependent K
Li H; Kim HW; Shin SE; Seo MS; An JR; Ha KS; Han ET; Hong SH; Firth AL; Choi IW; Han IY; Lee DS; Yim MJ; Park WS
Life Sci; 2017 Nov; 188():1-9. PubMed ID: 28855109
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the vasodilatory effects of canagliflozin in the rabbit thoracic aorta: Involvement of the SERCA pump and Kv channels.
Seo MS; An JR; Kang M; Heo R; Park H; Han ET; Han JH; Chun W; Park WS
Life Sci; 2021 Dec; 287():120101. PubMed ID: 34715136
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic omarigliptin dilates rabbit aorta by activating voltage-dependent K
Heo R; Kang M; Mun SY; Park M; Han ET; Han JH; Chun W; Park H; Jung WK; Choi IW; Park WS
Fundam Clin Pharmacol; 2023 Feb; 37(1):75-84. PubMed ID: 36093990
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol induces vasodilation through the activation of Ca(2+)-activated K(+) channels in aortic smooth muscle.
Li H; Hong DH; Son YK; Na SH; Jung WK; Bae YM; Seo EY; Kim SJ; Choi IW; Park WS
Vascul Pharmacol; 2015 Jul; 70():15-22. PubMed ID: 25748552
[TBL] [Abstract][Full Text] [Related]
16. The antidiabetic drug ipragliflozin induces vasorelaxation of rabbit femoral artery by activating a Kv channel, the SERCA pump, and the PKA signaling pathway.
Park M; Mun SY; Zhuang W; Jeong J; Kim HR; Park H; Han ET; Han JH; Chun W; Li H; Park WS
Eur J Pharmacol; 2024 Jun; 972():176589. PubMed ID: 38631503
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin Relaxes Resistance Mesenteric Arteries by Stimulating Multiple Smooth Muscle Cell Voltage-Gated K
Hasan A; Hasan R
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639181
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine-induced vasodilation involves voltage-gated potassium channels in rat aorta.
Han WQ; Zhu DL; Wu LY; Chen QZ; Guo SJ; Gao PJ
Life Sci; 2009 May; 84(21-22):732-7. PubMed ID: 19268479
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the vasorelaxation of human internal mammary artery induced by (-)-epicatechin.
Novakovic A; Marinko M; Vranic A; Jankovic G; Milojevic P; Stojanovic I; Nenezic D; Ugresic N; Kanjuh V; Yang Q; He GW
Eur J Pharmacol; 2015 Sep; 762():306-12. PubMed ID: 26049011
[TBL] [Abstract][Full Text] [Related]
20. Irisin relaxes rat thoracic aorta: MEK1/2 signaling pathway, K
Demirel S; Sahinturk S; Isbil N; Ozyener F
Can J Physiol Pharmacol; 2022 May; 100(5):379-385. PubMed ID: 34826251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
